| Catalog Number | KRP042 | 
																		| Alias | Kallikrein-8(hK8), Kallikrein-8 , hK8, EC 3.4.21.118, Neuropsin, NP, Ovasin, Serine protease 19, Serine protease TADG-14, Tumor-associated differentially expressed gene 14 protein, NRPN, PRSS19, TADG14, UNQ283/PRO322,  | 
																		| Size | 20ug, 50ug, 100ug, 200ug, 1mg | 
																		| Product Description | Human KLK8(29-260 aa) | 
																		| Molecular Name | KLK8 | 
																		| Product Introduction | Kallikrein-8(hK8)属于丝氨酸蛋白酶,参与多种生理过程如神经修复。。 | 
																		| Molecular Weight | 37-39 kDa | 
																		| Expression System | HEK293F Cells | 
																		| Species | Human | 
																		| Concentration | 联系销售经理获得最新批次的浓度 | 
																		| Purity | ≥95% | 
																		| SDS-PAGE |   | 
																		| Purification | Affinity Purification | 
																		| Uniprot ID | O60259-1 | 
																		| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. | 
																		| Formulation | Supplied in PBS | 
																		| Shipping Condition | This product is shipped on ice packs or dry ice. | 
																		| Background | Serine protease which is capable of degrading a number of proteins such as casein, fibrinogen, kininogen, fibronectin and collagen type IV. Also cleaves L1CAM in response to increased neural activity. Induces neurite outgrowth and fasciculation of cultured hippocampal neurons. Plays a role in the formation and maturation of orphan and small synaptic boutons in the Schaffer-collateral pathway, regulates Schaffer-collateral long-term potentiation in the hippocampus and is required for memory acquisition and synaptic plasticity. Involved in skin desquamation and keratinocyte proliferation. Plays a role in the secondary phase of pathogenesis following spinal cord injury. {ECO:0000269|PubMed:16337200}. | 
																		| Endotoxin | < 0.1 EU per ug | 
																		| Biological Activity | Measured by its ability to cleave the fluorogenic peptide substrate Boc VPR-AMC. The specific activity is >500 pmol/min/µg, as measured underthe described conditions. | 
																		| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 |